Clinical Predictors of Good/Poor Response to Growth Hormone Treatment in Children with Idiopathic Short Stature
We identified younger age and further distance from target HSDS as clinical predictors of response to GHT in a heterogenous population of children with ISS. Future studies, designed to identify the genetic determinants of response to GHT, could further facilitate individualisation of GHT.
Authors
- Moshe Phillip (ORCID: https://orcid.org/0000-0002-6616-5612)
- Andrew Dauber (ORCID: https://orcid.org/0000-0003-4890-0262)
- Alexander A.L. Jorge (ORCID: https://orcid.org/0000-0003-2567-7360)
- Jean-Marc Ferran
- Navid Nedjatian (ORCID: https://orcid.org/0000-0002-0290-9803)
- Nicky Kelepouris (ORCID: https://orcid.org/0000-0003-2445-2338)
- Anne Helene Olsen
Institutions
- Children's National (US)
- Tel Aviv University (IL)
- Novo Nordisk (Denmark) (DK)
- Novo Nordisk (United States) (US)
- Novo Nordisk (Switzerland) (CH)
- Schneider Children's Medical Center (IL)
- Universidade Federal de São Paulo (BR)
Publication Details
- Journal
- Hormone Research in Paediatrics
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1159/000542579
- Citations
- 5
- Primary Topic
- Growth Hormone and Insulin-like Growth Factors
- Type
- article
- Field-Weighted Citation Impact
- 1.79
Funders
- Novo Nordisk